Gastric Cancers Produce a Highly Indicative Biomarker
January 9, 2024 | Terry Sharrer
“Here, we [gastroenterological surgeon at Nagoya University, Japan] conducted a single-institutional study to evaluate the diagnostic performance of serum stromal cell-derived factor 4 (SDF4) levels in cancer patients. . . . . The ability of human GC [gastric cancer] cell lines to both produce and secrete SDF4 was confirmed in vitro. In conclusion, serum SDF4 levels could be a promising candidate for a novel diagnostic biomarker for GC and other malignancies.” MORE
Image Credit: Nature